CLINICAL_TRIALS
trial_result
· 2015-12-21
Clinical Trial Update: Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma [Phase 3]
Summary
A Phase 3 trial evaluating two doses of tiotropium Respimat versus placebo in children with severe persistent asthma, reporting efficacy and safety outcomes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2015-12-21